Header Logo

Connection

Robert Axtell to Adjuvants, Immunologic

This is a "connection" page, showing publications Robert Axtell has written about Adjuvants, Immunologic.
Connection Strength

0.127
  1. Serum IL-17F does not predict poor response to IM IFNß-1a in relapsing-remitting MS. Neurology. 2012 Aug 07; 79(6):531-7.
    View in: PubMed
    Score: 0.100
  2. Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. J Clin Invest. 2013 Jun; 123(6):2447-63.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.